Cargando…

Characterization of the Modulatory Effect of Hydroxychloroquine on ACE2 Activity: New Insights in relation to COVID-19

Chloroquine (CQ) and hydroxychloroquine (HCQ) have shown the ability to inhibit in vitro viral replications of coronaviridae viruses such as SARS-CoV and SARS-CoV-2. However, clinical trial outcomes have been disparate, suggesting that CQ and HCQ antiviral mechanisms are not fully understood. Based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tichauer, Juan E., Soto, Dagoberto, Andresen, Max
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313324/ https://www.ncbi.nlm.nih.gov/pubmed/34337036 http://dx.doi.org/10.1155/2021/6614000

Ejemplares similares

ACE and ACE2: insights from Drosophila and implications for COVID-19
por: Herrera, Paul, et al.
Publicado: (2021)

COVID‐19: Understanding the impact of anti‐hypertensive drugs and hydroxychloroquine on the ACE1 and ACE2 in lung and adipose tissue in SHR and WKY rats
por: Corrêa, Beatriz Santos Geoffroy, et al.
Publicado: (2023)

Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update
por: Joshi, Gaurav, et al.
Publicado: (2021)

Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic
por: Romani, Serena, et al.
Publicado: (2020)

The Effects of Chloroquine and Hydroxychloroquine on ACE2-Related Coronavirus Pathology and the Cardiovascular System: An Evidence-Based Review
por: Chen, Li, et al.
Publicado: (2020)

Hydroxychloroquine-related psychiatric disorders in COVID-19 patients
Publicado: (2020)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Hydroxychloroquine and COVID-19: The endgame!
por: Deplanque, Dominique
Publicado: (2023)

Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism
por: Badraoui, Riadh, et al.
Publicado: (2021)

Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies
por: Baildya, Nabajyoti, et al.
Publicado: (2020)

Ethical issues related to the hydroxychloroquine treatment prescription for Covid-19
por: El Rhazi, K., et al.
Publicado: (2020)

New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
por: Hou, Yuan, et al.
Publicado: (2020)

Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors
por: Fu, Jia, et al.
Publicado: (2021)

Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19
por: García-Escobar, Artemio, et al.
Publicado: (2022)

Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights
por: Devarajan, Asokan, et al.
Publicado: (2020)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Is hydroxychloroquine beneficial for COVID-19 patients?
por: Li, Xing, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic
por: Brufsky, Adam
Publicado: (2020)

Hydroxychloroquine in the prevention of COVID-19 mortality
por: Jorge, April
Publicado: (2021)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Utility of Hypertonic Saline and Diazepam in COVID-19–Related Hydroxychloroquine Toxicity
por: Mahan, Keenan M., et al.
Publicado: (2021)

Effect of Lactamase Inhibitors on the Biosensor Penp during the Measurement of Lactam Antibiotics Concentration
por: Soto, Dagoberto, et al.
Publicado: (2019)

The Role of ACE, ACE2, and AGTR2 Polymorphisms in COVID-19 Severity and the Presence of COVID-19-Related Retinopathy
por: Jevnikar, Kristina, et al.
Publicado: (2022)

ACE polymorphisms and COVID-19-related mortality in Europe
por: Bellone, Matteo, et al.
Publicado: (2020)

Plasma and Renal Cortex Meropenem Concentrations in Patients Undergoing Percutaneous Renal Biopsy
por: Sepúlveda, Rodrigo A., et al.
Publicado: (2019)

Method Based on the β-Lactamase PenPC Fluorescent Labeled for β-Lactam Antibiotic Quantification in Human Plasma
por: Andresen, Max, et al.
Publicado: (2016)

Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19()
por: Monte-Serrano, Juan, et al.
Publicado: (2020)

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Publicado: (2020)

Does hydroxychloroquine reduce mortality for COVID-19?
por: GALLUS, Silvano, et al.
Publicado: (2020)

HYDROXYCHLOROQUINE AND COVID-19: A META-ANALYSIS
por: Ho, Kam Sing, et al.
Publicado: (2020)

Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
por: Cohen, Myron S.
Publicado: (2020)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

Rethinking the role of hydroxychloroquine in the treatment of COVID‐19
por: Meyerowitz, Eric A., et al.
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

COVID-19 and hydroxychloroquine: Is the wonder drug failing?
por: Paliani, Ugo, et al.
Publicado: (2020)

Hydroxychloroquine for COVID-19: Balancing contrasting claims
por: Horby, Peter W., et al.
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

Risks of hydroxychloroquine use for COVID-19 prophylaxis
por: Sachdeva, Muskaan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0p0uh58qi9osq0rb6m033je67r